Can You Take Ibuprofen with Mirtazapine?

Severity assessment

Informational. While no direct, severe interaction is explicitly documented for this specific pair, there are general considerations regarding the concomitant use of NSAIDs and serotonergic agents.

Mechanism (plain English)

Ibuprofen is a type of painkiller called a Non-Steroidal Anti-Inflammatory Drug (NSAID). It works by blocking certain natural substances in the body called cyclooxygenases (COX enzymes), which are involved in making prostaglandins. Prostaglandins contribute to pain, inflammation, and fever. By reducing prostaglandins, ibuprofen helps to relieve these symptoms. However, prostaglandins also play a role in protecting the stomach lining and helping blood to clot, so blocking them can increase the risk of stomach irritation or bleeding.

Mirtazapine is an antidepressant that works in a complex way on brain chemicals. It primarily increases the levels of serotonin and noradrenaline in the brain, which are important for mood regulation. It does this by blocking certain receptors (alpha-2 adrenergic receptors) and also by blocking specific serotonin receptors (5-HT2 and 5-HT3). While it's not a selective serotonin reuptake inhibitor (SSRI), its actions can still increase serotonin activity. When drugs that increase serotonin levels are combined, there's a theoretical risk of a condition called serotonin syndrome, which is an excess of serotonin in the brain.

Evidence level

Regulator-flagged (for general NSAID gastrointestinal risks and for mirtazapine's serotonergic activity with other serotonergic agents); Theoretical (for serotonin syndrome risk with this specific combination).

Top regulator advisories (cite verbatim or close paraphrase)

• TGA (Australia): No pair-specific public advisory found for ibuprofen and mirtazapine. The TGA-approved product information for ibuprofen generally advises caution with other anti-inflammatory medicines and notes interactions with anticoagulants, lithium, ACE inhibitors, beta-blockers, diuretics, methotrexate, cardiac glycosides, corticosteroids, zidovudine, probenecid, antidiabetic medicines, and phenytoin [1].
• MHRA / NICE (UK): No specific guidance found for the ibuprofen-mirtazapine interaction. The MHRA Summary of Product Characteristics (SmPC) for mirtazapine advises caution when co-administering with other serotonergic agents due to the risk of serotonin syndrome, and notes interactions with MAO inhibitors, alcohol, and benzodiazepines [2].
• FDA / CDC (US): No specific FDA safety communication or CDC guidance found for the ibuprofen-mirtazapine interaction. The FDA label for mirtazapine warns against concomitant use with MAOIs due to the risk of serotonin syndrome and discusses interactions with alcohol and diazepam, and drugs affecting hepatic metabolism [3]. General NSAID warnings from the FDA advise of increased risk of serious cardiovascular and gastrointestinal events.
• EMA (Europe): No specific EMA advisory found for this combination. EMA guidelines generally align with MHRA SmPC information regarding mirtazapine's serotonergic properties and potential interactions.

Clinical risk factors that elevate the danger

• Gastrointestinal bleeding: History of gastrointestinal ulcers or bleeding, advanced age, concurrent use of anticoagulants (e.g., warfarin), antiplatelet agents (e.g., aspirin), corticosteroids, or selective serotonin reuptake inhibitors (SSRIs). High doses or prolonged use of ibuprofen also increases this risk.
• Serotonin Syndrome (theoretical risk): Concurrent use of other serotonergic drugs (e.g., SSRIs, SNRIs, triptans, tramadol, St. John's Wort), pre-existing conditions affecting serotonin regulation, or genetic predispositions.
• Renal impairment: NSAIDs like ibuprofen can worsen kidney function, especially in patients with pre-existing renal issues, which could indirectly affect mirtazapine clearance.
• Cardiovascular disease: NSAIDs can increase the risk of cardiovascular thrombotic events, myocardial infarction, and stroke.

What a patient should be told

• Be aware of stomach upset or bleeding: Ibuprofen can sometimes irritate your stomach or, rarely, cause bleeding. If you experience severe stomach pain, black or tarry stools, or vomit that looks like coffee grounds, stop taking ibuprofen and seek urgent medical attention. This risk can be higher if you take other medications that affect bleeding or have a history of stomach problems.
• Watch for unusual symptoms: While less common with this combination, there's a very small chance of a condition called serotonin syndrome. Look out for symptoms like confusion, agitation, rapid heart rate, sweating, muscle stiffness or twitching, and uncontrolled shivering. If these occur, seek urgent medical help.
• Do not stop mirtazapine suddenly: Mirtazapine is an antidepressant, and it's important not to stop taking it suddenly without talking to your doctor, as this can lead to withdrawal symptoms or a return of your depressive symptoms.
• Discuss all medications with your doctor or pharmacist: Always inform your doctor or pharmacist about all medicines you are taking, including over-the-counter drugs, supplements, and herbal remedies, to ensure they are safe to use together.
• Consider alternatives for pain relief: If you regularly need pain relief while taking mirtazapine, discuss safer alternatives with your doctor or pharmacist, especially if you have risk factors for stomach bleeding.

Top 3 sources (with full citation)

1. Therapeutic Goods Administration (TGA). OTC Ibuprofen Product Information - Template. Australian Government Department of Health and Aged Care. Available at: https://www.tga.gov.au/sites/default/files/otc-template-pi-ibuprofen.rtf
2. Medicines and Healthcare products Regulatory Agency (MHRA). Mirtazapine 15 mg, 30 mg and 45 mg Film-coated Tablets - Summary of Product Characteristics. electronic Medicines Compendium (emc). Available at: https://www.medicines.org.uk/emc/product/531/smpc
3. U.S. Food and Drug Administration (FDA). REMERON (mirtazapine) tablets, for oral use. DailyMed. Updated July 23, 2012. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dd2f25f6-7688-48e1-92e7-aab152ff7413

Notes for the reviewing pharmacist

There is no explicit, high-level regulator warning or contraindication for the concomitant use of ibuprofen and mirtazapine. The primary concern arises from the known class effects of NSAIDs (increased GI bleeding risk) and the serotonergic activity of mirtazapine, which theoretically could contribute to serotonin syndrome, although this specific combination is not typically highlighted as a high-risk pair for serotonin syndrome in major drug interaction databases or product labels. The risk of GI bleeding is amplified if the patient is also on other medications that affect coagulation (e.g., SSRIs, anticoagulants, antiplatelets) or has a history of GI issues. Individual patient assessment, including co-morbidities and concomitant medications, is crucial. Monitoring for signs of GI bleeding and, less commonly, serotonin syndrome, is recommended. Patient education should focus on symptom recognition and the importance of discussing all medications with healthcare providers. The FDA label for mirtazapine is quite old (2012), and newer information might exist, but current searches did not yield more recent, specific warnings for this pair. The TGA PI for ibuprofen is a template, indicating general guidance rather than a specific product label. The MHRA SmPC for mirtazapine is more current and provides relevant general warnings for serotonergic agents.

Source metadata JSON